Sequential scintigraphic strategy for the differentiation of brain tumours

European Journal of Nuclear Medicine

Volumn 27, Issue 5, 2000, Pages 550-558

  Matheja, Peter ^a   Rickert, Christian ^a   Weckesser, Matthias ^a   Palkovic, Stefan ^a   Löttgen, Jan ^a   Riemann, Burkhard ^a   Kopka, Klaus ^a   Kuwert, Torsten ^a   Wassmann, Hansdetlef ^a   Paulus, Werner ^a   Schober, Otmar ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Brain tumour; Iodine 123 methyltyrosine; Single photon emission tomography; Thallium 201

Indexed keywords

IODINE 123; METIROSINE; THALLIUM 201;

ADULT; AGED; ARTICLE; BRAIN LYMPHOMA; BRAIN SCINTISCANNING; BRAIN TUMOR; DIAGNOSTIC ACCURACY; FEMALE; GLIOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; RADIATION DOSE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOMA; HUMANS; IODINE RADIOISOTOPES; MALE; METHYLTYROSINES; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THALLIUM RADIOISOTOPES;

EID: 0034023999     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050542     Document Type: Article

References (45)

1. 1. Bergström M, Ericson K, Hagenfeldt L, et al. PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids. J Comput Assist Tomogr 1987; 11: 208-213.
2. 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol 1987; 28: 673-681.
3. 3. Weber W, Bartenstein P, Gross MW, et al. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 1997; 38: 802-808.
4. 4. Kuwert T, Woesler B, Morgenroth C, et al. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. J Nucl Med 1998; 39: 23-27.
5. 68Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr 1985; 9: 683-689.
6. 6. Mosskin M, Ericson K, Hindmarsh T, et al. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 1989; 30: 225-232.
7. 11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 1991; 32: 197-202.
8. 123I]iodo-alpha-methyl tyrosine and SPECT. J Nucl Med 1989; 30: 110-112.
9. 9. Kuwert T, Morgenroth C, Woesler B, et al. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med 1996; 23: 1345-1353.
10. 10. Kuwert T, Probst-Cousin S, Woesler B, et al. Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. J Nucl Med 1997; 38: 1551-1555.
11. 124IMT and first clinical results. J Nucl Med 1990; 31: 281-286.
12. 123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids. J Nucl Med 1991; 32: 1225-1229.
13. 11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med 1997; 38: 517-522.
14. 18F-deoxyglucose. Eur J Nucl Med 1997; 24: 428-434.
15. 15. Woesler B, Kuwert T, Kurlemann G, et al. High amino acid uptake in a low-grade desmoplastic infantile ganglioglioma in a 14-year-old patient. Neurosurg Rev 1998; 21: 31-35.
16. 16. Weckesser M, Griessmeier M, Schmidt D, et al. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent. Eur J Nucl Med 1998; 25: 150-156.
17. 18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Eur J Nucl Med 1999; 26: 144-151.
18. 18. Atkins HL, Budinger TF, Lebowitz E, et al. Thallium-201 for medical use. Part 3. Human distribution and physical imaging properties. J Nucl Med 1977; 18: 133-140.
19. +)-ATPase activity with growth of normal and transformed cells. Exp Cell Res 1974; 87: 233-240.
20. 20. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71: 342-346.
21. 21. Dierckx RA, Martin JJ, Dobbeleir A, Crols R, Neetens I, De Deyn PP. Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994; 21:621-633.
22. 22. Ueda T, Kaji Y, Wakisaka S, et al. Time sequential single photon emission computed tomography studies in brain tumour using thallium-201. Eur J Nucl Med 1993; 20: 138-145.
23. 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994; 163: 1459-1465.
24. 24. Sjöholm H, Elmqvist D, Rehncrona S, Rosen I, Salford LG. SPECT imaging of gliomas with thallium-201 and technetium-99m-HMPAO. Acta Neural Scand 1995; 91: 66-70.
25. 25. Oriuchi N, Tomiyoshi K, Inoue T, et al. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med 1996; 37: 457-462.
26. 201Tl SPET for the differential diagnosis of cerebral lesions in AIDS patients. Nucl Med Commun 1997; 18: 741-750.
27. 27. Lorberboym M, Estok L, Machac J, et al. Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. J Nucl Med 1996; 37: 1150-1154.
28. 28. Kuikka JT, Tenhunen-Eskelinen M, Jurvelin J, Kiilianen H. Physical performance of the Siemens MultiSPECT 3 gamma camera. Nucl Med Commun 1993; 14: 490-497.
29. 29. Chang L. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; NS-26/2: 2780-2789.
30. 30. Jaszczak RJ, Greer KL, Floyd CE Jr, Harris CC, Coleman RE. Improved SPECT quantification using compensation for scattered photons. J Nucl Med 1984; 25: 893-900.
31. 31. Yoshii Y, Satou M, Yamamoto T, et al. The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 1993; 20: 39-45.
32. 32. Pietrzyk U, Herholz K, Heiss WD. Three-dimensional alignment of functional and morphological tomograms. J Comput Assist Tomogr 1990; 14: 51-59.
33. 123I-alpha-methyl tyrosine by brain tumours. Nucl Med Commun 1996; 17: 609-615.
34. 34. Lorberboym M, Mandell LR, Mosesson RE, et al. The role of thallium-201 uptake and retention in intracranial tumors after radiotherapy. J Nucl Med 1997; 38: 223-226.
35. 35. Taki S, Kakuda K, Kakuma K, et al. Contribution of thallium-201 single photon emission tomography to the differential diagnosis of brain tumors [abstract]. J Nucl Med 1997; 38 (Suppl): 116P.
36. 36. Lorberboym M, Wallach F, Estok L, et al. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. J Nucl Med 1998; 39: 1366-1369.
37. 11C-methionine uptake in brain tumors measured by positron emission tomography. J Neurooncol 1996; 27: 163-171.
38. 38. Messa C, Fazio F, Costa DC, Ell PJ. Clinical brain radionuclide imaging studies. Semin Nucl Med 1995; 25: 111-143.
39. 39. Rollins NK, Lowry PA, Shapiro KN. Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. Pediatr Neurosurg 1995; 22: 8-14.
40. 40. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987; 28: 47-52.
41. 41. Slizofski WJ, Krishna L, Katsetos CD, et al. Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology. Cancer 1994; 74: 3190-3197.
42. + uptake in cultured human glioma cells. Cell Mol Neurobiol 1995; 15: 351-360.
43. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998; 50: 1316-1322.
44. 44. Ogawa T, Kanno I, Hatazawa J, et al. Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographies 1994; 14: 101-110.
45. 45. Roelcke U, Radü EW, Hausmann O, Vontobel P, Maguire RP, Leenders KL. Tracer transport and metabolism in a patient with juvenile pilocytic astrocytoma. A PET study. J Neurooncol 1998; 36: 279-283.